Characterization of Bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIB
- 1 July 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 320 (1) , 1-6
- https://doi.org/10.1016/j.bbrc.2004.05.112
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphomaBlood, 2003
- Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cellsNature Immunology, 2003
- Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32)Leukemia, 2001
- Bcl10 Is a Positive Regulator of Antigen Receptor–Induced Activation of NF-κ B and Neural Tube ClosureCell, 2001
- BCL10 gene mutation in lymphomaBlood, 2000
- Nucleotide insertions and deletions within the homopolymeric runs of adenines and thymidines of BCL10 cDNAs in normal peripheral blood leukocytesBlood, 2000
- Lack of BCL10 Mutations in Germ Cell Tumors and B Cell LymphomasCell, 1999
- Absence of BCL10 Mutations in Human Malignant MesotheliomaCell, 1999
- Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)Nature Genetics, 1999
- Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor TypesCell, 1999